title: [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
abstract: OBJECTIVE
  Identification of a rationale for the appropriate uptake period for myocardial (18)F-FDG-PET imaging of patients with and without diabetes mellitus.
  
  
  METHODS
  In a subset of 27 patients, static 2D-PET examination was performed of patients with chronic coronary artery disease and known myocardial infarction. The patients fasted (at least 4 h) before examination. (18)F-FDG (330 +/- 20 MBq) was injected intravenously. The image quality was semiquantitativly determined by ROI-analysis and the myocardium-to-blood pool activity ratio (M/B) was calculated. I.) Scans 30, 60, and 90 min p. i. of 10 non-diabetic patients (60 g oral glucose loading one hour before FDG-injection, low-dose intravenous insulin bolus if necessary). II.) Scans 30, 60, and 90 min p. i. of 10 patients with known non-insulin dependent diabetes (20 g glucose, insulin bolus). III.) Scans 90 min p. i. of 7 patients with known non-insulin dependent diabetes and elevated fasting serum glucose level (140-200 mg/dl; insulin bolus, no glucose).
  
  
  RESULTS
  I.) The M/B ratio significantly increases in nondiabetic patients with the uptake time (30 min 1.95 +/- 0.20; 60 min 2.96 +/- 0.36; 90 min 3.78 +/- 0.43). II.) In patients with non-insulin dependent diabetes the M/B ratio also significantly increases with uptake time. Compared to non-diabetic patients group II reached smaller M/B values (30 min 1.56 +/- 0.10; 60 min 2.15 +/- 0.14; 90 min 2.71 +/- 0.19). III.) In the group of patients with elevated fasting serum glucose level (who only got insulin but no glucose loading) the M/B activity ratio 90 min p. i. was clearly inferior compared with diabetic patients after oral glucose loading and insulin administration (M/B 2.71 +/- 0.19 versus 2.16 +/- 0.07).
  
  
  CONCLUSIONS
  In static myocardial viability PET studies with (18)F-FDG an uptake time of 90 min yields image quality superior to that obtained after shorter uptake time.
authors.affiliation: Abteilung Nuklearmedizin, Radiologische Universitätsklinik Freiburg, Hugstetterstr. 55, 79106 Freiburg, Germany. ibrink@ukl.uni-freiburg.de
authors.forename: I
authors.initials: I
authors.lastname: Brink
authors.forename: E U
authors.initials: EU
authors.lastname: Nitzsche
authors.forename: M
authors.initials: M
authors.lastname: Mix
authors.forename: T
authors.initials: T
authors.lastname: Schindler
authors.forename: M
authors.initials: M
authors.lastname: Hentschel
authors.forename: S
authors.initials: S
authors.lastname: Högerle
authors.forename: E
authors.initials: E
authors.lastname: Moser
mesh_terms: D000368:Aged; D001692:Biological Transport; D003327:Coronary Disease / Q000000981:diagnostic imaging* / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000000981:diagnostic imaging / Q000378:metabolism; D003925:Diabetic Angiopathies / Q000000981:diagnostic imaging / Q000378:metabolism; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics*; D005947:Glucose / Q000378:metabolism*; D006321:Heart / Q000000981:diagnostic imaging*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000000981:diagnostic imaging* / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D012016:Reference Values; D013997:Time Factors; D014055:Tomography, Emission-Computed / Q000379:methods
chemical_list: D019788:Fluorodeoxyglucose F18; D005947:Glucose